alka-seltzer plus severe cold powerfast fizz night
Generic: aspirin, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine bitartrate
Labeler: bayer healthcare llc.Drug Facts
Product Profile
Brand Name
alka-seltzer plus severe cold powerfast fizz night
Generic Name
aspirin, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine bitartrate
Labeler
bayer healthcare llc.
Dosage Form
TABLET, EFFERVESCENT
Routes
Active Ingredients
aspirin 500 mg/1, dextromethorphan hydrobromide 10 mg/1, doxylamine succinate 6.25 mg/1, phenylephrine bitartrate 7.8 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0280-0021
Product ID
0280-0021_45237a72-86fa-3324-e063-6394a90a003d
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2020-04-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
02800021
Hyphenated Format
0280-0021
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
alka-seltzer plus severe cold powerfast fizz night (source: ndc)
Generic Name
aspirin, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine bitartrate (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
- 10 mg/1
- 6.25 mg/1
- 7.8 mg/1
Packaging
- 10 POUCH in 1 CARTON (0280-0021-01) / 2 TABLET, EFFERVESCENT in 1 POUCH
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45237a72-86fa-3324-e063-6394a90a003d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0016500587590"], "unii": ["R16CO5Y76E", "9D2RTI9KYH", "V9BI9B5YI2", "27O3Q5ML57"], "rxcui": ["1536503"], "spl_set_id": ["a2b30c27-b836-f09f-e053-2995a90ac383"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Bayer HealthCare LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CARTON (0280-0021-01) / 2 TABLET, EFFERVESCENT in 1 POUCH", "package_ndc": "0280-0021-01", "marketing_start_date": "20200401"}], "brand_name": "Alka-Seltzer Plus Severe Cold Powerfast Fizz Night", "product_id": "0280-0021_45237a72-86fa-3324-e063-6394a90a003d", "dosage_form": "TABLET, EFFERVESCENT", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Antihistamine [EPC]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Histamine Receptor Antagonists [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "0280-0021", "generic_name": "aspirin, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine bitartrate", "labeler_name": "Bayer HealthCare LLC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Alka-Seltzer Plus Severe Cold Powerfast Fizz Night", "active_ingredients": [{"name": "ASPIRIN", "strength": "500 mg/1"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "10 mg/1"}, {"name": "DOXYLAMINE SUCCINATE", "strength": "6.25 mg/1"}, {"name": "PHENYLEPHRINE BITARTRATE", "strength": "7.8 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20200401", "listing_expiration_date": "20261231"}